X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1176) 1176
Paper (683) 683
Publication (446) 446
Report (195) 195
Data Set (5) 5
Book / eBook (2) 2
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
experiment (742) 742
cern lhc coll (717) 717
experimental results (710) 710
physics (700) 700
high energy physics - experiment (672) 672
particle physics (662) 662
physics - high energy physics - experiment (597) 597
cms (549) 549
p p: scattering (548) 548
high energy physics (524) 524
p p: colliding beams (490) 490
physics of elementary particles and fields (376) 376
13000 gev-cms (366) 366
phenomenology (344) 344
particle physics - experiment (267) 267
scattering [p p] (251) 251
hep (230) 230
nuclear experiment (222) 222
colliding beams [p p] (213) 213
8000 gev-cms (212) 212
hadron-hadron scattering (204) 204
background (202) 202
ex (172) 172
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (152) 152
supersymmetry (118) 118
transverse momentum: missing-energy (114) 114
physics, particles & fields (110) 110
channel cross section: upper limit (107) 107
cern lab (106) 106
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (101) 101
mass dependence (96) 96
final state:jet lepton (95) 95
elementary particles, quantum field theory (92) 92
quantum field theories, string theory (92) 92
astrophysics (91) 91
transverse momentum dependence (87) 87
classical and quantum gravitation, relativity theory (80) 80
quantum physics (80) 80
data analysis method (79) 79
top: pair production (78) 78
kinematics (77) 77
bottom: particle identification (76) 76
jet: bottom (75) 75
rapidity dependence (75) 75
high energy astrophysical phenomena (74) 74
z0: leptonic decay (71) 71
channel cross section: branching ratio: upper limit (68) 68
muon: pair production (67) 67
astronomy & astrophysics (66) 66
higgs particle: hadroproduction (66) 66
nuclear physics (66) 66
114 physical sciences (63) 63
quantum chromodynamics: perturbation theory (63) 63
final state:jet dilepton (62) 62
channel cross section: measured (59) 59
instrumentation and detectors (59) 59
jet: transverse momentum (55) 55
mass spectrum: (55) 55
nuclear and high energy physics (55) 55
transverse momentum (53) 53
differential cross section: measured (52) 52
electroweak interaction (50) 50
lead (50) 50
bottom: pair production (49) 49
new physics: search for (49) 49
squark: pair production (47) 47
w: leptonic decay (47) 47
beyond standard model (46) 46
mass: lower limit (46) 46
physics, nuclear (45) 45
sensitivity (45) 45
upper limit [channel cross section] (45) 45
collisions (44) 44
jet lepton (44) 44
jet: multiplicity (44) 44
final state:jet (43) 43
7000 gev-cms (42) 42
numerical calculations: monte carlo (42) 42
physics and astronomy (42) 42
missing-energy [transverse momentum] (41) 41
gravitation (40) 40
higgs particle: hadronic decay (40) 40
higher-order: 1 (40) 40
narrow resonance (40) 40
rapidity (40) 40
z0: associated production (40) 40
signature (39) 39
large hadron collider (38) 38
structure (38) 38
tau: pair production (38) 38
dijet (36) 36
hep-ex (36) 36
pair production [top] (36) 36
resonance: production (36) 36
stop: mass: lower limit (36) 36
física (34) 34
phase space (34) 34
bottom [jet] (33) 33
higgs physics (33) 33
luminosity (33) 33
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature reviews cancer, ISSN 1474-175X, 04/2017, Volume 17, Issue 4, pp. 254 - 268
Journal Article
STEM CELLS, ISSN 1066-5099, 09/2013, Volume 31, Issue 9, pp. 1954 - 1965
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2015, Volume 10, Issue 6, pp. e0131241 - e0131241
Blocking the enzyme Fatty Acid Synthase (FASN) leads to apoptosis of HER2-positive breast carcinoma cells. The hypothesis is that blocking FASN, in combination... 
GROWTH-FACTOR RECEPTOR | ANTICANCER ACTIVITY | BODY-WEIGHT | GREEN TEA | CELLS | HER2-TARGETED THERAPY | FOOD-INTAKE | MULTIDISCIPLINARY SCIENCES | PROSTATE-CANCER | OVARIAN-CANCER | TRASTUZUMAB RESISTANCE | Neoplasm Transplantation | Gallic Acid - pharmacology | Humans | Drug Resistance, Neoplasm | Dose-Response Relationship, Drug | Antibodies, Monoclonal, Humanized - pharmacology | Female | Antineoplastic Agents - pharmacology | Receptor, ErbB-2 - antagonists & inhibitors | Trastuzumab - pharmacology | Gallic Acid - analogs & derivatives | Catechin - pharmacology | Sirolimus - analogs & derivatives | Neoplasm Invasiveness | Mice, SCID | Breast Neoplasms - drug therapy | Cell Adhesion | Sirolimus - pharmacology | Fatty Acid Synthase, Type I - antagonists & inhibitors | Naphthalenes - pharmacology | Animals | Signal Transduction - drug effects | Cell Line, Tumor | Mice, Inbred NOD | Catechin - analogs & derivatives | Mice | Mutation | Quinazolines - pharmacology | Drugs | Enzymes | Catechin | Synthesis | Analysis | Breast cancer | Fatty acids | TOR protein | Biomedical research | Toxicity | AKT protein | Biochemistry | Kinases | Cancer therapies | Anticancer properties | Proteins | Breast carcinoma | Epidermal growth factor | Polyphenols | Biocompatibility | Epidermal growth factor receptors | Epigallocatechin-3-gallate | Extracellular signal-regulated kinase | ErbB-2 protein | Patients | Fatty-acid synthase | Molecular chains | Medicine | Signaling | Molecular modelling | Medical prognosis | Epigenetics | Breast | Antitumor activity | Ligands | Molecular biology | Trastuzumab | Cancer | Apoptosis | Tumors | Index Medicus | Cell interaction | Interaccions dels medicaments | Interacció cel·lular | Terapèutica | Drug interactions | Therapeutics | Càncer de mama
Journal Article
NATURE REVIEWS CANCER, ISSN 1474-175X, 10/2017, Volume 17, Issue 10, p. 632
This corrects the article DOI: 10.1038/nrc.2016.140. 
ONCOLOGY | Xenografts | Cancer
Journal Article
Nature, ISSN 0028-0836, 11/2010, Volume 468, Issue 7320, pp. 103 - 107
RANK ligand (RANKL), a TNF-related molecule, is essential for osteoclast formation, function and survival through interaction with its receptor RANK(1,2).... 
CELL FUNCTION | OSTEOPROTEGERIN-LIGAND | MULTIDISCIPLINARY SCIENCES | MEDROXYPROGESTERONE ACETATE | RECEPTOR | HORMONE REPLACEMENT THERAPY | HUMAN BREAST-TUMORS | OSTEOCLAST DIFFERENTIATION | EXPRESSION | GLAND DEVELOPMENT | TRANSGENIC MICE | Epithelial Cells - metabolism | RANK Ligand - metabolism | Progesterone - administration & dosage | Epithelial Cells - drug effects | Humans | Progestins - adverse effects | Cell Transformation, Neoplastic - chemically induced | Mammary Neoplasms, Experimental - metabolism | Mammary Neoplasms, Experimental - genetics | Breast Neoplasms - metabolism | Lung Neoplasms - secondary | Mammary Neoplasms, Experimental - pathology | Medroxyprogesterone Acetate - adverse effects | Female | Precancerous Conditions - pathology | Receptor Activator of Nuclear Factor-kappa B - metabolism | Disease Models, Animal | 9,10-Dimethyl-1,2-benzanthracene - administration & dosage | Neoplasm Invasiveness | Mice, Inbred C57BL | Epithelial Cells - pathology | Mice, Transgenic | Progesterone - adverse effects | Mammary Neoplasms, Experimental - chemically induced | RANK Ligand - genetics | Animals | RANK Ligand - antagonists & inhibitors | Breast Neoplasms - pathology | Progestins - administration & dosage | Receptor Activator of Nuclear Factor-kappa B - genetics | Cell Proliferation - drug effects | Medroxyprogesterone Acetate - administration & dosage | Mice | Cell Transformation, Neoplastic - drug effects | Precancerous Conditions - prevention & control | Cell Transformation, Neoplastic - pathology | Mammary Tumor Virus, Mouse - genetics | Mammary Tumor Virus, Mouse - physiology | 9,10-Dimethyl-1,2-benzanthracene - adverse effects | Immunohistochemistry | Care and treatment | Usage | Physiological aspects | Breast cancer | Genetic aspects | Research | Progesterone | Tumor proteins | Health aspects | Risk factors | Proteins | Hormone replacement therapy | Rodents | Apoptosis | Index Medicus
Journal Article
by Chatrchyan, S and Khachatryan, V and Sirunyan, A.M and Tumasyan, A and Adam, N and Adam, W and Aguilo, E and Bergauer, T and Dragicevic, M and Erö, J and Fabjan, C and Friedl, M and Frühwirth, R and Ghete, V.M and Hammer, J and Hoch, M and Hörmann, N and Hrubec, J and Jeitler, M and Kiesenhofer, W and Knünz, V and Krammer, M and Krätschmer, I and Liko, D and Majerotto, W and Mikulec, I and Pernicka, M and Rahbaran, B and Rohringer, H and Rohringer, C and Schöfbeck, R and Strauss, J and Szoncsó, F and Taurok, A and Waltenberger, W and Walzel, G and Widl, E and Wulz, C.-E and Chekhovsky, V and Emeliantchik, I and Litomin, A and Makarenko, V and Mossolov, V and Shumeiko, N and Solin, A and Stefanovitch, R and Suarez Gonzalez, J and Fedorov, A and Korzhik, M and Missevitch, O and Zuyeuski, R and Bansal, M and Bansal, S and Beaumont, W and Cornelis, T and De Wolf, E.A and Druzhkin, D and Janssen, X and Luyckx, S and Mucibello, L and Ochesanu, S and Roland, B and Roland, C and Roland, G and Rougny, R and Selvaggi, G and Selvaggi, M and Staykova, Z and Van Haevermaet, H and Van Mechelen, P and Van Remortel, N and Van Spilbeeck, A and Blekman, F and Blyweert, S and DʼHondt, J and Devroede, O and Gonzalez Suarez, R and Goorens, R and Kalogeropoulos, A and Maes, M and Olbrechts, A and Tavernier, S and Van Doninck, W and Van Lancker, L and Van Mulders, P and Van Onsem, G.P and Villella, I and Clerbaux, B and De Lentdecker, G and Dero, V and Dewulf, J.P and Gay, A.P.R and Hreus, T and Léonard, A and Marage, P.E and Mohammadi, A and Reis, T and Rugovac, S and Thomas, S and Thomas, M and ... and CMS Collaboration and Los Alamos National Lab. (LANL), Los Alamos, NM (United States) and Argonne National Lab. (ANL), Argonne, IL (United States) and Fermi National Accelerator Lab. (FNAL), Batavia, IL (United States) and Lawrence Livermore National Lab. (LLNL), Livermore, CA (United States)
Physics Letters B, ISSN 0370-2693, 09/2012, Volume 716, Issue 1, pp. 30 - 61
Journal Article